- Home
- MGNI vs WGS Comparison
MGNI vs WGS Comparison
Compare MGNI & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGNI
- WGS
- Stock Information
- Founded
- MGNI 2007
- WGS 2017
- Country
- MGNI United States
- WGS United States
- Employees
- MGNI N/A
- WGS N/A
- Industry
- MGNI Computer Software: Programming Data Processing
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- MGNI Technology
- WGS Technology
- Exchange
- MGNI Nasdaq
- WGS Nasdaq
- Market Cap
- MGNI 2.5B
- WGS 2.0B
- IPO Year
- MGNI N/A
- WGS N/A
- Fundamental
- Price
- MGNI $15.44
- WGS $69.48
- Analyst Decision
- MGNI Strong Buy
- WGS Strong Buy
- Analyst Count
- MGNI 14
- WGS 5
- Target Price
- MGNI $18.39
- WGS $80.60
- AVG Volume (30 Days)
- MGNI 1.6M
- WGS 787.4K
- Earning Date
- MGNI 02-26-2025
- WGS 02-18-2025
- Dividend Yield
- MGNI N/A
- WGS N/A
- EPS Growth
- MGNI N/A
- WGS N/A
- EPS
- MGNI 0.12
- WGS N/A
- Revenue
- MGNI $661,134,000.00
- WGS $267,228,000.00
- Revenue This Year
- MGNI $0.60
- WGS $43.70
- Revenue Next Year
- MGNI $10.37
- WGS $17.28
- P/E Ratio
- MGNI $129.80
- WGS N/A
- Revenue Growth
- MGNI 8.71
- WGS 29.41
- 52 Week Low
- MGNI $8.38
- WGS $2.85
- 52 Week High
- MGNI $18.38
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- MGNI 43.70
- WGS 40.28
- Support Level
- MGNI $14.89
- WGS $66.81
- Resistance Level
- MGNI $16.44
- WGS $98.87
- Average True Range (ATR)
- MGNI 0.66
- WGS 7.98
- MACD
- MGNI -0.16
- WGS -2.10
- Stochastic Oscillator
- MGNI 20.52
- WGS 8.33
About MGNI Magnite Inc.
Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.